Updates on COVID-19 (including visitor restrictions and mask requirements), monkeypox and flu. See Communicable Disease Updates

Your browser is out-of-date!

Internet Explorer 11 has been retired by Microsoft as of June 15, 2022. To get the best experience on this website, we recommend using a modern browser, such as Safari, Chrome or Edge.

×

Scripps Diabetes Researcher Presents Weekly Insulin Study Results

Scripps Whittier Institute for Diabetes plays lead role in testing experimental therapy

A man holding a bottle of insulin with a syringe also in his hand, illustrating a diabetic patient administering insulin.

Scripps Whittier Institute for Diabetes plays lead role in testing experimental therapy

Scripps Whittier Institute for Diabetes’ leading role in the global effort to develop long-acting insulin was on full display recently when the institute’s corporate vice president, Athena Philis-Tsimikas, MD, presented encouraging clinical trial results at a major medical conference in Stockholm.


Dr. Philis-Tsimikas was a lead investigator in the study that compared an experimental weekly insulin shot to the more typical one-a-day insulin shot in patients with type 2 diabetes.

Media Contact

Keith Darce
858-678-7121